1. Home
  2. GLU vs ASRT Comparison

GLU vs ASRT Comparison

Compare GLU & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gabelli Global Utility of Beneficial Ownership

GLU

Gabelli Global Utility of Beneficial Ownership

HOLD

Current Price

$18.74

Market Cap

110.5M

Sector

Finance

ML Signal

HOLD

Logo Assertio Holdings Inc.

ASRT

Assertio Holdings Inc.

HOLD

Current Price

$0.72

Market Cap

75.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLU
ASRT
Founded
2004
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.5M
75.1M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
GLU
ASRT
Price
$18.74
$0.72
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
12.4K
313.9K
Earning Date
01-01-0001
11-10-2025
Dividend Yield
8.60%
N/A
EPS Growth
N/A
N/A
EPS
0.62
N/A
Revenue
N/A
$137,354,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$22.50
N/A
Revenue Growth
N/A
9.22
52 Week Low
$11.61
$0.51
52 Week High
$15.40
$1.01

Technical Indicators

Market Signals
Indicator
GLU
ASRT
Relative Strength Index (RSI) 63.04 41.47
Support Level $18.36 $0.75
Resistance Level $18.65 $0.80
Average True Range (ATR) 0.19 0.04
MACD 0.02 -0.00
Stochastic Oscillator 73.64 23.22

Price Performance

Historical Comparison
GLU
ASRT

About GLU Gabelli Global Utility of Beneficial Ownership

Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: